APVO Aptevo Therapeutics - announces new solid tumor strategy - SEC filing - Files patent application for nectin-4 X pd-l1 dual-targeting ba

APVO Aptevo Therapeutics - announces new solid tumor strategy - SEC filing - Files patent application for nectin-4 X pd-l1 dual-targeting backbone - SEC filing